A detailed history of Kuhn & CO Investment Counsel transactions in Zoetis Inc. stock. As of the latest transaction made, Kuhn & CO Investment Counsel holds 1,086 shares of ZTS stock, worth $194,079. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,086
Holding current value
$194,079
% of portfolio
0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $187,421 - $213,377
1,086 New
1,086 $212 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $177,336 - $234,305
1,171 New
1,171 $231 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Kuhn & CO Investment Counsel Portfolio

Follow Kuhn & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kuhn & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Kuhn & CO Investment Counsel with notifications on news.